On the mechanism of potentiation of kinins by inhibitors of the fibrinolytic system.
D000614:Aminocaproates / Q000494:pharmacology; D000804:Angiotensin II / Q000378:metabolism*; D000818:Animals; D001920:Bradykinin / Q000378:metabolism*; D002268:Carboxypeptidases / Q000378:metabolism; D004600:Eledoisin / Q000378:metabolism*; D006168:Guinea Pigs; D007082:Ileum / Q000187:drug effects / Q000201:enzymology; D007609:Kallidin / Q000378:metabolism*; D009119:Muscle Contraction / Q000187:drug effects
D000614:Aminocaproates; D000804:Angiotensin II; D007609:Kallidin; D004600:Eledoisin; D002268:Carboxypeptidases; D001920:Bradykinin